The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Trends in the development of chiral drugs
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Putting chirality to work: the strategy of chiral switches
Agranat, I., Caner, H., & Caldwell, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd915 · Cited by 637
Self-citationFDA'S policy statement for the development of new stereoisomeric drugs
(1992) · Chirality · doi:10.1002/chir.530040513 · Cited by 581
ROUHI, A. M. (2003) · Chemical & Engineering News Archive · doi:10.1021/cen-v081n018.p045 · Cited by 182
Protecting America's health: the FDA, business, and one hundred years of regulation
(2004) · Choice Reviews Online · doi:10.5860/choice.41-2838 · Cited by 174
STINSON, S. C. (2001) · Chemical & Engineering News · doi:10.1021/cen-v079n040.p079 · Cited by 154
Intellectual property and chirality of drugs
Agranat, I., & Caner, H. (1999) · Drug Discovery Today · doi:10.1016/s1359-6446(99)01363-x · Cited by 131
Self-citationStereochemical aspects of drug action and disposition
Eichelbaum, M. F., & Gross, A. S. (2003) · Adelaide Research & Scholarship (AR&S) (University of Adelaide) · doi:10.1016/s0065-2490(96)80003-7 · Cited by 107
ROUCHI, A. M. (2002) · Chemical & Engineering News · doi:10.1021/cen-v080n023.p043 · Cited by 59
Cited by
Spirooxindoles: Promising scaffolds for anticancer agents
Yu, B., Yu, D.-Q., & Liu, H.-M. (2015) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.06.056 · Cited by 867
The Significance of Chirality in Drug Design and Development
H. Brooks, W., C. Guida, W., & G. Daniel, K. (2011) · Current Topics in Medicinal Chemistry · doi:10.2174/156802611795165098 · Cited by 694
Chiral HPLC for efficient resolution of enantiomers
Okamoto, Y., & Ikai, T. (2008) · Chemical Society Reviews · doi:10.1039/b808881k · Cited by 515
The market of chiral drugs: Chiral switches versus de novo enantiomerically pure compounds
Calcaterra, A., & D’Acquarica, I. (2018) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.07.008 · Cited by 481
Pharmacologically active compounds in the environment and their chirality
Kasprzyk-Hordern, B. (2010) · Chemical Society Reviews · doi:10.1039/c000408c · Cited by 456
Metadata
- Authors
- Caner, H., Groner, E., Levy, L., & Agranat, I.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2004-02
- Volume
- 9
- Issue
- 3
- Pages
- 105-110
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2006585685
- Cited by
- 399
- References
- 8
- FWCI
- 4.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Trends in the development of chiral drugs. https://app.cochat.ai/papers/10.1016/s1359-6446(03)02904-0
- The paper
- Caner, H., Groner, E., Levy, L., & Agranat, I. (2004). Trends in the development of chiral drugs. Drug Discovery Today. https://doi.org/10.1016/s1359-6446(03)02904-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.